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Secondary achalasia due to submucosal invasion of cardia by gastric cancer is a rare condition.We report a case of pseudoachalasia,
secondary to the involvement of gastroesophageal junction by poorly differentiated gastric cancer, initially mistaken as idiopathic
form. We focus on the difficulty to establish differential diagnosis only on the basis of routine exams and we stress the necessity
of “second level” instrumental exams; EUS in routine workup in selected patients should be considered. We support that routine
workup based on history, clinical presentation, radiological and endoscopic findings, and certainlymanometry could be insufficient
for a correct differential diagnosis between primary and secondary forms in some patients.
1. Introduction
Achalasia is a rare primarymotility disorder of the esophagus
that affects one person in 100.000 per year [1–3], consisting in
absence of peristalsis and incomplete relaxation of frequently
hypertensive lower esophageal sphincter (LES) in response
to swallowing [4]. The disease was first described more than
300 years ago as “food blockage in esophagus” but the exact
pathogenesis still remains enigmatic [5]. Achalasia can be
primary [idiopathic] or secondary. The most common form
of achalasia is the idiopathic one. Similar clinical presentation
can occur in patients with pseudoachalasia (2–4% of patients
with achalasia) or Chagas disease. Diagnosis is based on a
careful clinical history, correct interpretation of anamnesis,
and presentation of symptoms, barium swallow, endoscopy,
and esophageal manometry. However, sometimes differential
diagnosis might not be easy by “routine” methods in the
initial evaluation as demonstrated by several cases [6–8],
because clinical presentation can mimic idiopathic one; this
often results in a substantial delay in diagnosis and treatment
until surgery.
2. Case Report
A 51-year-old man suffered from progressive dysphagia to
solids for over about 6 months and slow weight loss of
5 kg was referred to our institution with the presumptive
diagnosis of achalasia. Preoperative workup consisted in a
careful clinical history, correct interpretation of anamnesis,
and symptoms; then esophagogastroduodenoscopy was per-
formed and showed a dilated esophagus without evident
mucosal lesion, and the passage through the cardia was
more difficult: “crossing snap” passage. Manometry revealed
absence of peristalsis and impaired swallow-induced LES
relaxation with classic manometric pattern (Figure 1). The
barium swallow showed an emptying defect with “bird beak”
sign and narrowing at esophageal junction (Figure 2). We
made a diagnosis of esophageal achalasia and performed a
laparoscopic Heller’s myotomywithDor fundoplication (Fig-
ures 3 and 4). We use the laparoscopic approach to perform
this kind of surgery. Several studies demonstrate that this is
the best way to treat this pathology. We use Veres’ needle
placed in Palmer’s point to create pneumoperitoneum and
Hindawi Publishing Corporation
Case Reports in Surgery
Volume 2014, Article ID 654917, 5 pages
http://dx.doi.org/10.1155/2014/654917
2 Case Reports in Surgery
Figure 1: Manometry.
Figure 2: Barium swallow showing emptying defect with “bird
beak” sign and narrowing at esophageal junction.
Figure 3: Laparoscopic Heller’s myotomy.
then we place five trocars: the first 10–12mm trocar is placed
in supraumbilical region, two 10–12mm trocars in right and
left side, and two 5mm trocars in paraxiphoid region and
left iliac region [9]. The surgical exploration of peritoneal
cavity does not reveal any anatomic abnormality or suspect
neoplastic lesions or secondary localizations. Two months
after surgery, the patient complained of worsening dysphagia.
We repeated several esophagogastroduodenoscopies with
numerous biopsies that showed only cardia inflammation and
were negative for malignancy. Tumor markers were negative
too. Balloon dilatation was performed to improve symptoms.
Figure 4: Dor fundoplication.
Figure 5: EUS.
Persisting dysphagia, one month after we performed EUS
with biopsies, showed infiltrating gastric adenocarcinoma of
the cardia (T3 WHO, Siewert II) (Figure 5). After staging
CT scan, total gastroesophagectomy was performed, with D2
lymph-node resection and Roux-en-Y reconstruction. The
surgical specimen contained a thick, hard tumor 3,6 × 2,5
× 1,3 cms located in the gastroesophageal junction (Siewert
II), extensively infiltrating the wall and reaching in some
areas the subserosal layer (Figures 6(a) and 6(b)).Histological
finding was “poorly differentiated adenocarcinoma (WHO:
G3)” (Figures 7(a) and 7(b)).
3. Discussion
The first description of this condition was made by Willis
T. (1674), who treated these patients with dilatators made
of whale bone and sponge. The term achalasia is a Greek
word meaning “failure of relaxation” which was first coined
by Hurst in 1927. Idiopathic form is caused by inflamma-
tion of myenteric plexus, injury and subsequential loss of
inhibitory ganglion cells, and fibrosis of myenteric nerves.
There is a reduction in the synthesis of nitric oxide and
vasoactive intestinal polypeptide [10]. Several studies tried to
identify the agents that may cause the disease; the etiology
of primary achalasia is maybe an autoimmune-mediated
destruction of inhibitory neurons in response to an unknown
insult, in genetically susceptible ones. However, the exact
pathogenesis of primary achalasia is still poorly known; a
definite “trigger” has not been identified [11]. Pseudoachalasia
is a clinical syndrome due to several malignant tumors,
which can mimic idiopathic form. The pathophysiology of
pseudoachalasia is still not well understood too. Differ-
ent theories have been proposed: intraluminal narrowing,




extra luminal compression, infiltration of the myenteric
plexus, metabolic disturbance, and paraneoplastic effects
as endocrine abnormalities (e.g., hypercalcaemia) that may
result in interference on the controls and coordination of
neural plexus on the swallowing mechanism or in vagal
neuropathy and subsequent degeneration of plexus ganglia
[12, 13]. The most common cause of pseudoachalasia is
the compression of esophagus by an extraluminal [14, 15]
mass; 71% of the cases result from a gastric adenocarcinoma
at the gastroesophageal junction [16, 17]. Usually, in these
cases the esophagogastric junctional mucosa remains intact,
without superficial macroscopic lesion; the mass may have
the appearance of a benign intramural lesion [17]. However
several malignancies could be cause of this disorder such as
gastric adenocarcinomas, bronchial origin adenocarcinoma
and oat cell tumors, squamous cell carcinoma of the esoph-
agus, Hodgkin/Non-Hodgkin’s lymphoma, pleural mesothe-
lioma, hepatocellular carcinoma, prostatic adenocarcinoma,
breast adenocarcinoma, colonic adenocarcinoma, pancreatic
(a)
(b)
Figure 7: Histological finding was “poorly differentiated adenocar-
cinoma.”
adenocarcinoma renal cell carcinoma, and squamous cell
carcinoma of the cervix [18]. The myenteric plexus may
be infiltrated directly or attacked by host’s immune system
that creates autoantibodies in response to surface tumour
antigens that can cross-react leading to nerve injury and
damage [19, 20] Achalasia has also been reported due to
antineuronal antibodies (anti-Hu, anti-Yo, and N-type Ca2+
channel antineuronal antibodies) especially in patients with
small cell lung cancer [21, 22]. Achalasia can also be part
of complex syndrome such as Allgrove syndrome, Down’s
syndrome, or familial visceral neuropathy [23]. Differential
diagnosis is often difficult, but it is mandatory because
pseudoachalasia is due to neoplasms of the gastroesophageal
junction: it should be excluded.
Progressive dysphagia to solid followed by liquids is the
most characteristic symptom of primary achalasia [24, 25].
However, dysphagia in achalasia secondary to malignancy is
relatively short in duration and usually develops in advanced
phases of pathology. Although a secondary form of achalasia
due to esophageal or gastric cancer involving the cardia
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could be easily diagnosed through upper gastrointestinal
endoscopy, if the malignancy spreads into submucosal layer
or is a very aggressive and poorly differentiated histological
type, it can be very difficult to diagnose it until surgery [26].
In a literature review a total of 264 cases of pseudoacha-
lasia were found in 122 publications [27]. Most cases of
these were due to malignant disease (53.9% primary and
14.9% secondary malignancy), followed by benign lesions
(12.6%) and complications of surgical procedures at the distal
esophagus or proximal stomach (11.9%). Rarely, the disease
was consequence of paraneoplastic process with destruction
of the myenteric plexus (2.6%).
In a more recent research, other authors report 155
publications with data of 302 patients diagnosed with pseu-
doachalasia [28]. These studies show that primary malignan-
cies of the esophagus or esophagogastric junction accounted
for 50% of cases of secondary achalasia, followed by sec-
ondary malignancies (18%), such as metastases (12%), which
primarily originated from lung and breast. Benign causes,
including mesenchymal tumors, secondary amyloidosis, and
peripheral neuropathy, accounted for 14% of patients with
pseudoachalasia. In 12%, themotor abnormality occurred as a
consequence of gastroesophageal surgery, namely, antireflux
surgery. Rare causes of pseudoachalasia were neurological
disorders (3.5%) or paraneoplastic syndromes (2.5%) in the
context of small cell carcinoma, bronchial carcinoid, gastric
carcinoma, and pleural mesothelioma. However, none of
these paraneoplastic syndromes was associated with medi-
astinal or esophageal infiltration by the primary tumor.
4. Conclusion
Secondary achalasia due tomalignant disease is an infrequent
disorder. It should be suspected in elderly patients who
have had a significant weight loss but a short duration of
symptoms. Pseudoachalasia represents a significant diagnos-
tic challenge, with clinical, radiological, manometric, and
endoscopic features that may be indistinguishable from acha-
lasia. As reported in this unfortunate case,multiple diagnostic
procedures may lead to inappropriate diagnostic conclusion
of a benign etiology. When the clinical presentation suggests
a malignancy that cannot be identified by routine evaluation,
an endoscopic ultrasound and then a fine CT scan should
be performed. EUS could be the “keystone” to diagnostic
success, with attributes of high image resolution with close
proximity to the lesion, compared with CT andmagnetic res-
onance imaging which may lack sensitivity for small lesions.
EUS also facilitates acquisition of a tissue sample, adding
further to its utility in the diagnostic workup of patients in
which pseudoachalasia is suspected. EUS represents a valu-
able tool in the evaluation of pseudoachalasia, particularly
where clinical suspicion is high and other modalities have
been unrevealing [29, 30]. Considering the patient’s age, the
lack of evidence for malignancy in the clinical history, and
the findings in the first endoscopy and biopsies, we argue
that it may be appropriate to amend the preoperative workup
for achalasia introduction of EUS among routine exams to
reduce the delay in diagnosis.
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